The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor Barrier
Abstract
Ligand-mediated drug delivery systems have enormous potential for improving the efficacy of cancer treatment. In particular, Arg-Gly-Asp peptides are promising ligand molecules for targeting αvβ3/αvβ5 integrins, which are overexpressed in angiogenic sites and tumors, such as intractable human glioblastoma (U87MG). We here achieved highly efficient drug delivery to U87MG tumors by using a platinum anticancer drug-incorporating polymeric micelle (PM) with cyclic Arg-Gly-Asp (cRGD) ligand molecules. Intravital confocal laser scanning microscopy revealed that the cRGD-linked polymeric micelles (cRGD/m) accumulated rapidly and had high permeability from vessels into the tumor parenchyma compared with the PM having nontargeted ligand, "cyclic-Arg-Ala-Asp" (cRAD). As both cRGD/m- and cRAD-linked polymeric micelles have similar characteristics, including their size, surface charge, and the amount of incorporated drugs, it is likely that the selective and accelerated accumulation of cRGD/m into tumors occurred via an active internalization pathway, possibly transcytosis, thereby producing significant antitumor effects in an orthotopic mouse model of U87MG human glioblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Self-citationThe dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Self-citationRole of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Self-citationRGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847
A reevaluation of integrins as regulators of angiogenesis
Hynes, R. O. (2002) · Nature Medicine · doi:10.1038/nm0902-918 · Cited by 548
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.1.45 · Cited by 456
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
Muldoon, L. L., Soussain, C., Jahnke, K., Johanson, C., Siegal, T., Smith, Q. R., Hall, W. A., Hynynen, K., Senter, P. D., Peereboom, D. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9861 · Cited by 417
Jiao, H., Wang, Z., Liu, Y., Wang, P., & Xue, Y. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9496-4 · Cited by 411
Drug and Gene Delivery to the Brain
Pardridge, W. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01054-1 · Cited by 405
Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., Chen, Y., Wang, X., Jiang, Y., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.044 · Cited by 384
Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X.-R., Du, J., Ying, X., Lu, W.-L., Lou, J.-N., & Wei, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 303
Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
Nabors, L. B., Mikkelsen, T., Rosenfeld, S. S., Hochberg, F., Akella, N. S., Fisher, J. D., Cloud, G. A., Zhang, Y., Carson, K., Wittemer, S. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6514 · Cited by 290
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Murakami, M., Cabral, H., Matsumoto, Y., Wu, S., Kano, M. R., Yamori, T., Nishiyama, N., & Kataoka, K. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001385 · Cited by 262
Self-citationDevelopment of novel targeted therapies in the treatment of malignant glioma
Rich, J. N., & Bigner, D. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1380 · Cited by 247
Cabral, H., Nishiyama, N., Okazaki, S., Koyama, H., & Kataoka, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.022 · Cited by 201
Self-citationTaga, T., Suzuki, A., Gonzalez‐Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., & Laug, W. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10265 · Cited by 198
New Treatment Strategies for Malignant Gliomas
Avgeropoulos, N. G., & Batchelor, T. T. (1999) · The Oncologist · doi:10.1634/theoncologist.4-3-209 · Cited by 182
Cabral, H., Nishiyama, N., & Kataoka, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.024 · Cited by 161
Self-citationRecent advances in brain tumor-targeted nano-drug delivery systems
Liu, Y., & Lu, W. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.682726 · Cited by 161
Endothelial Vesicles in the Blood–Brain Barrier: Are They Related to Permeability?
Stewart, P. A. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007026504843 · Cited by 145
EFFECT OF THE ANGIOGENESIS INHIBITOR CILENGITIDE (EMD 121974) ON GLIOBLASTOMA GROWTH IN NUDE MICE
Yamada, S., Bu, X., Khankaldyyan, V., Gonzales-Gomez, I., McComb, J. G., & Laug, W. E. (2006) · Neurosurgery · doi:10.1227/01.neu.0000245622.70344.be · Cited by 135
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule‐dependency
Mikkelsen, T., Brodie, C., Finniss, S., Berens, M. E., Rennert, J. L., Nelson, K. K., Lemke, N. W., Brown, S. L., Hahn, D., Neuteboom, B., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24240 · Cited by 134
Nomoto, T., Matsumoto, Y., Miyata, K., Oba, M., Fukushima, S., Nishiyama, N., Yamasoba, T., & Kataoka, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.011 · Cited by 128
Self-citationCo-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
Zhan, C., Wei, X., Qian, J., Feng, L., Zhu, J., & Lu, W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.022 · Cited by 112
Quantitative study of microvessel ultrastructure in human peritumoral brain tissue
Stewart, P. A., Hayakawa, K., Farrell, C. L., & Maestro, R. F. D. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.67.5.0697 · Cited by 109
Sarin, H. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-77 · Cited by 89
Experimental approaches for the treatment of malignant gliomas
Arko, L., Katsyv, I., Park, G. E., Luan, W. P., & Park, J. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.015 · Cited by 81
Function and Antagonism of β Integrins in the Development of Cancer Therapy
Sheldrake, H. M., & Patterson, L. H. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788486713 · Cited by 73
Matsumoto, Y., Nomoto, T., Cabral, H., Matsumoto, Y., Watanabe, S. T., Christie, R. J., Miyata, K., Oba, M., Ogura, T., Yamasaki, Y., et al. (2010) · Biomedical Optics Express · doi:10.1364/boe.1.001209 · Cited by 69
Self-citationExpression of claudin‐5 in dermal vascular endothelia
Morita, K., Sasaki, H., Furuse, K., Furuse, M., Tsukita, S., & Miyachi, Y. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120309.x · Cited by 68
The efficacy of temozolomide for recurrent glioblastoma multiforme
Chen, C., Xu, T., Lu, Y., Chen, J., & Wu, S. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03778.x · Cited by 58
Self-citationGlioblastoma therapy: going beyond Hercules Columns
Mangiola, A., Anile, C., Pompucci, A., Capone, G., Rigante, L., & BONIS, P. D. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.158 · Cited by 50
Standard of care therapy for malignant glioma and its effect on tumor and stromal cells
Jones, T. S., & Holland, E. C. (2011) · Oncogene · doi:10.1038/onc.2011.398 · Cited by 48
Drug delivery to brain tumours: challenges and progress
Ningaraj, N. S. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.499 · Cited by 41
Fink, K., Mikkelsen, T., Nabors, B., Ravin, P. D., Plotkin, S. R., Schiff, D., Hicking, C., Picard, M. A., & Reardon, D. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2010 · Cited by 34
Claudin-5 Expression in In Vitro Models of the Blood–Brain Barrier
Cooper, I., Malina, K. C.-K., & Teichberg, V. I. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-185-7_25 · Cited by 20
Advances in malignant glioma drug discovery
Reardon, D. A., Perry, J., Brandes, A. A., Jalali, R., & Wick, W. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.584530 · Cited by 19
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Self-citationTumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Polymer–drug conjugate therapeutics: advances, insights and prospects
Ekladious, I., Colson, Y. L., & Grinstaff, M. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0005-0 · Cited by 855
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837
Self-citation
Metadata
- Authors
- Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., Cabral, H., Nishiyama, N., & Kataoka, K.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-09-18
- Volume
- 7
- Issue
- 10
- Pages
- 8583-8592
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2001257757
- Cited by
- 454
- References
- 49
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.